Future studies could benefit from the integration of additional obesity‐related biomarkers, such as lipid profiles, fasting glucose, inflammatory markers (e.g., C‐reactive protein, interleukin‐6), and adipokines (e.g., leptin, adiponectin). This evidence concerns the gene LEP and obesity disorder.